Stock Upgrades and Downgrades Calendar

View today's upgrades and downgrades and other equity ratings changes directly from brokerage firms.

Last Updated: 21-May-26 08:27 ET

Thursday, May 21

COVERAGE INITIATED

Aligos Therapeutics (ALGS)
Brokerage Firm: Cantor Fitzgerald | Action: Initiated | Ratings Change: Overweight | Price Tgt: $20

Brown & Brown (BRO)
Brokerage Firm: Citizens | Action: Initiated | Ratings Change: Mkt Outperform | Price Tgt: $70

Connect Biopharma (CNTB)
Brokerage Firm: Cantor Fitzgerald | Action: Initiated | Ratings Change: Overweight | Price Tgt: $4

Eupraxia Pharmaceuticals (EPRX)
Brokerage Firm: Stifel | Action: Initiated | Ratings Change: Buy | Price Tgt: $25

JBT Marel Corporation (JBTM)
Brokerage Firm: Oppenheimer | Action: Initiated | Ratings Change: Outperform | Price Tgt: $175

MapLight Therapeutics (MPLT)
Brokerage Firm: Craig Hallum | Action: Initiated | Ratings Change: Buy | Price Tgt: $43

Oculis Holding AG (OCS)
Brokerage Firm: Guggenheim | Action: Initiated | Ratings Change: Buy | Price Tgt: $75

Opus Genetics (IRD)
Brokerage Firm: Leerink Partners | Action: Initiated | Ratings Change: Outperform | Price Tgt: $10

Protagonist Therapeutics (PTGX)
Brokerage Firm: Wolfe Research | Action: Initiated | Ratings Change: Outperform | Price Tgt: $135

SailPoint (SAIL)
Brokerage Firm: Roth Capital | Action: Initiated | Ratings Change: Buy | Price Tgt: $19

Tamboran Resources (TBN)
Brokerage Firm: Roth Capital | Action: Initiated | Ratings Change: Buy | Price Tgt: $47

V.F. Corp (VFC)
Brokerage Firm: Citigroup | Action: Initiated | Ratings Change: Neutral | Price Tgt: $18